Panteleev Mikhail A, Ovanesov Mikhail V, Kireev Dmitrii A, Shibeko Aleksei M, Sinauridze Elena I, Ananyeva Natalya M, Butylin Andrey A, Saenko Evgueni L, Ataullakhanov Fazoil I
Laboratory of Physical Biochemistry of Blood, National Research Center for Hematology, Russian Academy of Medical Sciences, Moscow, Russia.
Biophys J. 2006 Mar 1;90(5):1489-500. doi: 10.1529/biophysj.105.069062. Epub 2005 Dec 2.
Blood coagulation in vivo is a spatially nonuniform, multistage process: coagulation factors from plasma bind to tissue factor (TF)-expressing cells, become activated, dissociate, and diffuse into plasma to form enzymatic complexes on the membranes of activated platelets. We studied spatial regulation of coagulation using two approaches: 1), an in vitro experimental model of clot formation in a thin layer of plasma activated by a monolayer of TF-expressing cells; and 2), a computer simulation model. Clotting in factor VIII- and factor XI-deficient plasmas was initiated normally, but further clot elongation was impaired in factor VIII- and, at later stages, in factor XI-deficient plasma. The data indicated that clot elongation was regulated by factor Xa formation by intrinsic tenase, whereas factor IXa was formed by extrinsic tenase on activating cells and diffused into plasma, thus sustaining clot growth. Far from the activating cells, additional factor IXa was produced by factor XIa. Exogenously added TF had no effect on the clot growth rate, suggesting that plasma TF does not contribute significantly to the clot propagation process in a reaction-diffusion system without flow. Addition of thrombomodulin at 3-100 nM caused dose-dependent termination of clot elongation with a final clot size of 2-0.2 mm. These results identify roles of specific coagulation pathways at different stages of spatial clot formation (initiation, elongation, and termination) and provide a possible basis for their therapeutic targeting.
血浆中的凝血因子与表达组织因子(TF)的细胞结合,被激活,解离,并扩散到血浆中,在活化血小板的膜上形成酶复合物。我们使用两种方法研究了凝血的空间调节:1),在由单层表达TF的细胞激活的薄层血浆中形成凝块的体外实验模型;2),计算机模拟模型。在缺乏因子VIII和因子XI的血浆中凝血正常启动,但在缺乏因子VIII的血浆中以及在后期阶段,缺乏因子XI的血浆中凝块的进一步延长受到损害。数据表明,凝块延长受内源性凝血酶原酶形成的因子Xa调节,而因子IXa由激活细胞上的外源性凝血酶原酶形成并扩散到血浆中,从而维持凝块生长。在远离激活细胞的地方,因子XIa产生额外的因子IXa。外源性添加的TF对凝块生长速率没有影响,这表明在没有流动的反应扩散系统中,血浆TF对凝块传播过程没有显著贡献。添加3 - 100 nM的血栓调节蛋白会导致凝块延长的剂量依赖性终止,最终凝块大小为2 - 0.2毫米。这些结果确定了特定凝血途径在空间凝块形成的不同阶段(启动、延长和终止)的作用,并为其治疗靶向提供了可能的基础。